18/06/2014 - 22:00
Tofacitinib was superior to methotrexate at reducing the signs and symptoms of rheumatoid arthritis, improving physical function, and slowing the progression of joint damage in a 2-year, phase III...
Field of Interest: Rheumatology
Categories:
News Feed: Internal Medicine News - Rheumatology